Abstract | BACKGROUND: The clinical use of cisplatin (cis-diamminedichloro- platinum II, CDDP) is highly limited by its nephrotoxicity. Although N-acetylcysteine (NAC), a thiol-containing antioxidant, has been documented to be effective in attenuating renal injury induced by CDDP, the precise mechanisms involved in its renoprotection have not been completely clarified. METHODS: RESULTS: NAC blocked oxidative stress, p38 MAPK activation, caspase-3 cleavage, tissue apoptosis, renal dysfunction and morphological damage induced by CDDP. CDDP-triggered NF-kappaB translocation into the nucleus and TNF-alpha mRNA increase in the kidney were also inhibited in NAC-treated rats. MT downregulated the TNF-alpha mRNA level, and PDTC inhibited the increases in both NF-kappaB translocation and TNF-alpha mRNA. Neither MT nor PDTC were capable of interfering with oxidative stress, p38 MAPK phosphorylation, caspase-3 cleavage, tissue apoptosis and kidney injury induced by CDDP. CONCLUSIONS: These data suggest that oxidative stress and p38 MAPK-mediated apoptotic cell death pathways are involved, at least in part, in the pathogenesis of CDDP-induced ARF, and negative regulation of p38 MAPK activation through inhibition of oxidative stress appears to play a central role in the beneficial effects of NAC.
|
Authors | Jinghui Luo, Takayuki Tsuji, Hideo Yasuda, Yuan Sun, Yoshihide Fujigaki, Akira Hishida |
Journal | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
(Nephrol Dial Transplant)
Vol. 23
Issue 7
Pg. 2198-205
(Jul 2008)
ISSN: 1460-2385 [Electronic] England |
PMID | 18385389
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Antioxidants
- Cross-Linking Reagents
- Free Radical Scavengers
- NF-kappa B
- Thiocarbamates
- Tumor Necrosis Factor-alpha
- prolinedithiocarbamate
- Proline
- p38 Mitogen-Activated Protein Kinases
- Melatonin
- Cisplatin
- Acetylcysteine
|
Topics |
- Acetylcysteine
(pharmacology, therapeutic use)
- Acute Kidney Injury
(chemically induced, drug therapy, metabolism)
- Animals
- Antineoplastic Agents
(toxicity)
- Antioxidants
(pharmacology)
- Cisplatin
(toxicity)
- Cross-Linking Reagents
- Disease Models, Animal
- Free Radical Scavengers
(pharmacology, therapeutic use)
- Male
- Melatonin
(pharmacology)
- NF-kappa B
(metabolism)
- Oxidative Stress
(drug effects)
- Proline
(analogs & derivatives, pharmacology)
- Rats
- Rats, Sprague-Dawley
- Thiocarbamates
(pharmacology)
- Tumor Necrosis Factor-alpha
(metabolism)
- p38 Mitogen-Activated Protein Kinases
(metabolism)
|